An investor explains why they continue buying shares of PepsiCo, Main Street Capital, and Verizon, highlighting their strong dividend yields (3.8%-6.9%), consistent dividend growth records, and reliable cash flows that support passive income generation and financial independence.

The global consumer healthcare market is experiencing a structural shift where regulatory compliance and FDA approval have become critical competitive advantages. Major companies including Philip Morris, Celsius Holdings, USANA Health Sciences, and Medifast are advancing strategic initiatives focused on regulatory readiness, product integration, and market expansion. Doseology Sciences has partnered with McKinney Regulatory Science Advisors to strengthen its FDA pathway for oral pouch products.

Celsius Holdings rebounded 74% in 2025 after a 52% decline in 2024, driven by recovery from a temporary inventory issue with PepsiCo. The company reported 75% top-line growth through Q3 2025, with the core Celsius brand growing 13% organically. Growth drivers include the Alani Nu acquisition and international expansion, which currently represents only 3% of revenue. The author maintains a positive outlook for 2026 despite acknowledging the valuation has become more attractive at a P/S ratio of 6.

Motley Fool contributors Jason Hall, Jon Quast, and Dan Caplinger discuss strategies for building sustainable investing habits in 2026. They share personal mistakes and lessons learned, emphasizing the importance of focusing on business fundamentals, maintaining psychological resilience through market downturns, and developing consistent habits rather than relying on New Year's resolutions. Key strategies include delaying earnings reviews, dollar-cost averaging, and building portfolios around companies you genuinely believe in.

Vita Coco, a coconut water brand, has outperformed competitors with a 46% stock gain in 2025, boasting a more attractive price-to-earnings ratio compared to Celsius and benefiting from tariff relief and sustainability initiatives.

Celsius Holdings experienced strong growth in 2025 after acquiring Alani Nu for $1.8 billion, with revenue surging 173%. The key focus for 2026 will be maintaining growth momentum in the second quarter when year-over-year comparisons become more challenging.

Celsius, a health-focused energy drink company, experienced remarkable 7,330% stock growth before declining 58% from its peak. Despite strong revenue growth and potential international expansion, the company faces challenges with inventory buildup and limited brand recognition compared to market leaders.

Celsius, a fast-growing beverage company, experienced stock decline after disappointing investors with its latest financial performance, raising questions about potential investment opportunities.

Celsius Holdings reported 173% revenue growth in Q3 2025, driven by acquisitions of Alani Nu and Rockstar brands. Despite a net loss and stock price decline, the company shows promising growth potential with expanding international markets and improving profit margins.

Seascape Capital Management initiated a new $4.3 million position in Monster Beverage, purchasing 64,258 shares, representing 1.2% of its reportable U.S. equity assets as of September 30, 2025.

The article discusses three potential high-growth stocks in the AI and consumer sectors, highlighting Advanced Micro Devices, Celsius Holdings, and Micron Technology as promising investments with potential to double in value within two years.

Coca-Cola reported negative free cash flow due to a strategic Fairlife acquisition, while Celsius Holdings demonstrates strong organic growth and earnings potential in the energy drink market.